Promotion and PR

WASHINGTON - The FDA last week disclosed that it is working on a guidance document about "the dissemination of press releases by sponsors, or on their behalf, containing information concerning investigational drugs," and asked for public comments on guidance documents

Read the full 409 word article

How to gain access

Continue reading with a
two-week free trial.